正文:参考文献
程中华,熊文坚. 肝硬化患者细胞免疫功能和内毒素血症的关系。胃肠病学和肝病学杂志,2010,19(1):31-32.
Qin HM. Influence of intestinal detergent by different administration on bowel mucosa permeabililty and serum endotoxin level in patients with liver cirrhosis. Chinese General Pratice, 2012, 15 (6):674-676.
Chen YP, Zhong ZH, Liang YH, et al. Effect of microbial ecological agent on the function of intestinal mucosa biarrier in cirrhosis patients. Chinese Journal of Gastroenterology, 2010,22 (4): 204-207.
EE. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of Hepatology, 2010, 53 (3):397-417.
Cesaro C, Tiso A, Del Prete A, et al. Gut microbiota and probiotics in chronic liver diseases[J]. Dig Liver Dis, 2011,43 (6): 431-8,20.
Gomez-Hurtado I, Santacruz A,Peiro G,et a1.Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis.J Hepatol,2011, 54:245-245.
Gupta A, Dhiman RK, Kumari, et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transist time in cirrhotic patients with minimal hepatic encephalopathy[J]. J Hepatol, 2010,53 (5):849-855.
Nolan JP. The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology, 2010,52 (5):1829-1835.
Wang Y, Lu S, WangZ, et al. Effect of selective gut decontamination in regulation of inflammatory reaction in patients with systemic inflammatory response syndrome. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2015,27(6):484-488.
Jiang SM, Jia L, Zhang MH. Probiotic and lactulose: influence on gastrointestinal flora and PH value in minimal hepatic encephalopathy rats. Int J Clin Exp Med, 2015,8 (6): 9996-10000.
Chu JK, Ru XL, Yang T, et al. The clinical effect of lactulose and bifid lriple viable on intestinal barrier function and inflammatory cytokine in cirrhosis patients with spontaneous bacterial peritonitis. Chin J Diffic and Compl Cas, 2011,10 (4):270-272.
3/3 首页 上一页 1 2 3